Integrated-Protection-Technologies near Steinbach MB (479 Result(s))

IMRIS provides an optimized fully integrated image guided therapy environment in a unique hybrid OR that delivers timely information on surgical targets and results to clinicians for use during surgical or interventional procedures. The VISIUS Surgical Theatre incorporates magnetic resonance imaging (MRI), CT and fluoroscopy into multi-purpose surgical suites to provide truly intraoperative imaging for specific medical applications by bringing advanced imaging into the OR. Our products are sold globally to hospitals that deliver clinical services to patients in the neurosurgical, interventional, and orthopedic markets.The VISIUS Surgical Theatre is designed to address the important needs of patients, clinicians and hospitals.PatientsPeer reviewed and published data show the degree of tumor resection is increased in the VISIUS Surgical Theatre because residual tumor is found during intraoperative imaging. More complete tumor removal means increased survival and reduced re-operation rates.

TeraGo Networks (TSX: TGO) provides Canadian businesses with the Internet, data networking, colocation, and cloud services they need to move and store data. Colocation solutions are provided by Data Centers Canada, a division of TeraGo Networks. We own and manage our national IP network, providing service to over 45 major markets across the country. TeraGo is proud to help businesses save on costs and operate with greater efficiency by providing complimentary IT services that meet their telecom and data needs. With the performance of a major carrier and the customer service of a small business - your business is not just another number.

Wound Biofilm© MSU-CBE, all rights reservedKane Biotech Inc. is dedicated to the research and development of products to prevent and disperse microbial biofilms. The Company was formed in 2001 and is developing products for the prevention and dispersal of biofilms focused on the genetic mechanisms of biofilm formation, and originally based upon the discovery of over 60 novel anti-biofilm targets. Kane Biotech Inc. uses a patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. The Company has evidence that this technology has potential to significantly improve the ability to prevent and/or destroy biofilms in several medical and industrial applications.Biofilms are estimated to be responsible for 80% of all human infections and cost industry, cities and hospitals in excess of $500 billion each year.Kane Biotech has a growing pipeline of products based on the Company's ability to screen for factors affecting biofilm formation and has resulted in the development of candidate products based on the demand for safe and effective anti-biofilm compounds.VisionTo become a global leader in creating innovative technology to breakdown and disperse biofilms and to develop unique products that have a positive impact on human health